TDRD7 Gene Cataract Autosomal Recessive Congenital Type 4 NGS Genetic DNA Test
Comprehensive Genetic Testing for Congenital Cataracts
The TDRD7 Gene Cataract Autosomal Recessive Congenital Type 4 NGS Genetic DNA Test represents a breakthrough in pediatric ophthalmology diagnostics. This advanced genetic test specifically targets mutations in the TDRD7 gene, which plays a crucial role in lens development and transparency. Congenital cataracts affecting infants and young children can lead to significant vision impairment if not detected early, making this test an essential tool for proactive eye health management.
What Does This Test Measure?
This sophisticated NGS-based genetic test performs comprehensive analysis of the TDRD7 gene to identify pathogenic variants associated with autosomal recessive congenital type 4 cataracts. The test examines:
- Complete TDRD7 gene sequencing for mutation detection
- Identification of single nucleotide polymorphisms (SNPs)
- Detection of insertions, deletions, and copy number variations
- Analysis of gene expression patterns related to lens development
- Assessment of autosomal recessive inheritance patterns
Who Should Consider This Test?
This genetic test is recommended for individuals presenting with:
- Infants with congenital cataracts or cloudy lens appearance
- Children experiencing progressive vision loss in early childhood
- Patients with family history of inherited eye disorders
- Individuals with unexplained bilateral cataracts in infancy
- Couples planning pregnancy with family history of congenital cataracts
- Patients with developmental delays associated with vision problems
Key Benefits of TDRD7 Genetic Testing
- Early Diagnosis: Enables prompt intervention before vision impairment becomes permanent
- Personalized Treatment: Guides customized surgical and therapeutic approaches
- Family Planning: Provides crucial information for genetic counseling and reproductive decisions
- Proactive Management: Allows for monitoring and early intervention strategies
- Accurate Prognosis: Helps predict disease progression and potential complications
Understanding Your Test Results
Your genetic test results will be carefully interpreted by our team of certified genetic counselors and ophthalmology specialists. Results typically fall into three categories:
- Positive Result: Indicates the presence of TDRD7 gene mutations associated with congenital cataracts, requiring immediate ophthalmological consultation
- Negative Result: Suggests no detected mutations in the TDRD7 gene, though other genetic factors may still be considered
- Variant of Uncertain Significance: Identifies genetic changes whose clinical significance requires further investigation and monitoring
Test Pricing Information
| Test Description | Price (USD) |
|---|---|
| TDRD7 Gene Cataract Autosomal Recessive Congenital Type 4 NGS Genetic DNA Test – Discount Price | $500 |
| TDRD7 Gene Cataract Autosomal Recessive Congenital Type 4 NGS Genetic DNA Test – Regular Price | $700 |
Nationwide Testing Availability
We proudly offer comprehensive genetic testing services across the United States, with convenient locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our state-of-the-art laboratories ensure consistent, reliable results regardless of your location.
Take Action for Better Vision Health
Don’t let congenital cataracts compromise your child’s vision and development. Early genetic testing can make a significant difference in treatment outcomes and quality of life. Our experienced team is ready to guide you through the testing process and provide the comprehensive care your family deserves.
Book your TDRD7 Genetic Test today by calling +1(267) 388-9828 or schedule your appointment online. Take the first step toward understanding and managing congenital eye conditions with confidence.
